seasonal influenza vaccine (intradermal)

Seasonal influenza vaccine (intradermal) is an inactivated hemagglutinin (HA) vaccine developed by Daiichi Sankyo for the prevention of seasonal influenza. It is administered via the intradermal route using a specialized delivery system developed in collaboration with Terumo Corporation. By targeting the dermis, which contains a high density of dendritic cells and other antigen-presenting cells, the vaccine aims to stimulate a potent immune response. The vaccine contains purified HA antigens from specific influenza A and B strains as recommended for the seasonal period. This formulation allows for a reduced volume of vaccine compared to standard intramuscular injections while maintaining comparable immunogenicity.

Other names

Seasonal Influenza HA Vaccine (Intradermal) Daiichi Sankyointradermal influenza vaccine